Please login to the form below

Not currently logged in
Email:
Password:

asset swap

This page shows the latest asset swap news and features for those working in and with pharma, biotech and healthcare.

GlaxoSmithKline reportedly looking to sell select antibiotic brands

GlaxoSmithKline reportedly looking to sell select antibiotic brands

GSK gained the two vaccines as part of a $20bn asset swap with Novartis in 2015, which was orchestrated by previous GSK CEO Sir Andrew Witty.

Latest news

More from news
Approximately 3 fully matching, plus 53 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    This transaction came as a result of the requirement that Sanofi had to divest certain assets from the Sanofi/ Boehringer Ingelheim asset swap of December 2015, in which Sanofi swapped its

  • The human perspective The human perspective

    Chief among these moves were the German company's exit from the generics business, via a $2.6bn deal with specialty firm Hikma, and its forthcoming asset swap with Sanofi. ... But looking at how a transaction such as the yet-to-be-completed asset swap

  • Deal Watch December 2015 Deal Watch December 2015

    Headline $m. Sanofi / Boehringer Ingelheim. Boehringer Ingelheim / Sanofi. Asset swap. ... 200. Sinclair IS (UK). Alliance. Acquisition - asset. Marketed dermatology range of products (Nov 2015).

  • Pharma deals in June 2015 Pharma deals in June 2015

    Kythera's lead asset is Kybella, previously known as ATX-101, which is an FDA approved, proprietary injectable formulation of a synthetic version of deoxycholic acid for the reduction of submental ... This was the case following the $20bn asset swap deal

  • Allergan and taking a specialised approach Allergan and taking a specialised approach

    But for the likes of GSK, Novartis and Lilly with their asset swap agreement, Forest Laboratories and its acquisition of Actavis, and the various dealings at Merck &Co, BMS, Ranbaxy and

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics